Not Yet Recruiting
A Study to Evaluate the Safety and Efficacy of SCTB35 in Combination With Lenalidomide in Patients With Relapsed or Refractory Follicular Lymphoma
NCT07562022
- Conditions
- Follicular Lymphoma (FL), Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
- Locations
-
- Beijing Cancer Hospital Beijing, Beijing Municipality, China